Literature DB >> 30602059

The role of neuro-immune interactions in cancer-related fatigue: Biobehavioral risk factors and mechanisms.

Julienne E Bower1.   

Abstract

Fatigue is a common and distressing symptom in both patients with cancer and cancer survivors. There is substantial variation in the severity and persistence of cancer-related fatigue that may be driven by individual differences in host factors, including characteristics that predate the cancer experience as well as responses to cancer and its treatment. This review examines biobehavioral risk factors linked to fatigue and the mechanisms through which they influence fatigue across the cancer continuum, with a focus on neuro-immune processes. Among psychosocial risk factors, childhood adversity is a strong and consistent predictor of cancer-related fatigue; other risk factors include history of depression, catastrophizing, lack of physical activity, and sleep disturbance, with compelling preliminary evidence for loneliness and trait anxiety. Among biologic systems, initial work suggests that alterations in immune, neuroendocrine, and neural processes are associated with fatigue. The identification of key risk factors and underlying mechanisms is critical for the development and deployment of targeted interventions to reduce the burden of fatigue in the growing population of cancer survivors. Given the multidimensional nature of fatigue, interventions that influence multiple systems may be most effective.
© 2019 American Cancer Society.

Entities:  

Keywords:  biobehavioral; fatigue; inflammation; neuro-immune; psychosocial

Mesh:

Year:  2019        PMID: 30602059      PMCID: PMC6502236          DOI: 10.1002/cncr.31790

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  120 in total

Review 1.  Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions.

Authors:  P Servaes; C Verhagen; G Bleijenberg
Journal:  Eur J Cancer       Date:  2002-01       Impact factor: 9.162

2.  Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer.

Authors:  J A Broeckel; P B Jacobsen; J Horton; L Balducci; G H Lyman
Journal:  J Clin Oncol       Date:  1998-05       Impact factor: 44.544

3.  Association of childhood trauma with fatigue, depression, stress, and inflammation in breast cancer patients undergoing radiotherapy.

Authors:  Tatiana J Han; Jennifer C Felger; Anna Lee; Donna Mister; Andrew H Miller; Mylin A Torres
Journal:  Psychooncology       Date:  2015-05-14       Impact factor: 3.894

4.  Prevalence, predictors, and characteristics of off-treatment fatigue in breast cancer survivors.

Authors:  Michael A Andrykowski; Kristine A Donovan; Christine Laronga; Paul B Jacobsen
Journal:  Cancer       Date:  2010-08-23       Impact factor: 6.860

5.  Diurnal cortisol dysregulation, functional disability, and depression in women with ovarian cancer.

Authors:  Aliza Z Weinrib; Sandra E Sephton; Koen Degeest; Frank Penedo; David Bender; Bridget Zimmerman; Clemens Kirschbaum; Anil K Sood; David M Lubaroff; Susan K Lutgendorf
Journal:  Cancer       Date:  2010-09-15       Impact factor: 6.860

Review 6.  Mind-body therapies and control of inflammatory biology: A descriptive review.

Authors:  Julienne E Bower; Michael R Irwin
Journal:  Brain Behav Immun       Date:  2015-06-23       Impact factor: 7.217

7.  Inflammatory biomarkers for persistent fatigue in breast cancer survivors.

Authors:  Alicia Collado-Hidalgo; Julienne E Bower; Patricia A Ganz; Steve W Cole; Michael R Irwin
Journal:  Clin Cancer Res       Date:  2006-05-01       Impact factor: 12.531

8.  What is the relationship between trait anxiety and depressive symptoms, fatigue, and low sleep quality following breast cancer surgery?

Authors:  J P M Lockefeer; J De Vries
Journal:  Psychooncology       Date:  2012-06-13       Impact factor: 3.894

9.  Associations among human papillomavirus, inflammation, and fatigue in patients with head and neck cancer.

Authors:  Canhua Xiao; Jonathan J Beitler; Kristin A Higgins; Toby Glazer; Linh Kha Huynh; Sudeshna Paul; Jennifer C Felger; Evanthia C Wommack; Nabil F Saba; Dong M Shin; Deborah W Bruner; Andrew H Miller
Journal:  Cancer       Date:  2018-05-09       Impact factor: 6.860

10.  Potential Role of Bupropion Sustained Release for Cancer-Related Fatigue: a Double-Blind, Placebo-Controlled Study

Authors:  Farzaneh Ashrafi; Sarah Mousavi; Mohammad Karimi
Journal:  Asian Pac J Cancer Prev       Date:  2018-06-25
View more
  30 in total

Review 1.  Hospitalization as an Opportunity to Optimize Glycemic Control in Oncology Patients.

Authors:  Amy Hiestand; James Flory; Ritika Chitkara
Journal:  Curr Diab Rep       Date:  2019-11-27       Impact factor: 4.810

2.  Inflammatory biomarkers and patient-reported outcomes in acute myeloid leukemia: Refocusing on older adults.

Authors:  Li-Wen Huang; Rebecca L Olin
Journal:  J Geriatr Oncol       Date:  2019-07-23       Impact factor: 3.599

3.  Relationship between circadian activity rhythms and fatigue in hospitalized children with CNS cancers receiving high-dose chemotherapy.

Authors:  Valerie E Rogers; Shijun Zhu; Belinda N Mandrell; Sonia Ancoli-Israel; Lianqi Liu; Pamela S Hinds
Journal:  Support Care Cancer       Date:  2019-07-04       Impact factor: 3.603

4.  Factor structure, reliability, inter-rater agreement and convergent validity of the parent and child Italian versions of the paediatric quality of life inventory multidimensional fatigue scale for children and adolescents in paediatric inpatients with obesity and their parents.

Authors:  Gian Mauro Manzoni; Matthew F Smout; Nicoletta Marazzi; Sofia Tamini; Alessandra De Col; Angela Sorgente; Margherita Lanz; Giada Pietrabissa; Gianluca Castelnuovo; Enrico Molinari; Alessandro Sartorio
Journal:  Eat Weight Disord       Date:  2021-03-30       Impact factor: 4.652

5.  Subgroups of patients undergoing chemotherapy with distinct cognitive fatigue and evening physical fatigue profiles.

Authors:  Lisa Morse; Kord M Kober; Carol Viele; Bruce A Cooper; Steven M Paul; Yvette P Conley; Marilyn Hammer; Jon D Levine; Christine Miaskowski
Journal:  Support Care Cancer       Date:  2021-07-04       Impact factor: 3.603

6.  Symptom Treatment Preferences of Cancer Survivors: Does Fatigue Level Make a Difference?

Authors:  Ellen Krueger; Ekin Secinti; Catherine E Mosher; Patrick V Stutz; Andrea A Cohee; Shelley A Johns
Journal:  Cancer Nurs       Date:  2021 Nov-Dec 01       Impact factor: 2.592

7.  Do all patients with cancer experience fatigue? A longitudinal study of fatigue trajectories in women with breast cancer.

Authors:  Julienne E Bower; Patricia A Ganz; Michael R Irwin; Steve W Cole; Deborah Garet; Laura Petersen; Arash Asher; Sara A Hurvitz; Catherine M Crespi
Journal:  Cancer       Date:  2021-02-19       Impact factor: 6.860

8.  Fatigue, anxiety, and quality of life in breast cancer patients compared to non-cancer controls: a nationwide longitudinal analysis.

Authors:  AnnaLynn M Williams; Carly Paterson Khan; Charles E Heckler; Debra L Barton; Mary Ontko; Jodi Geer; Amber S Kleckner; Shaker Dakhil; Jerry Mitchell; Karen M Mustian; Luke J Peppone; Victor Kipnis; Charles S Kamen; Ann M O'Mara; Michelle C Janelsins
Journal:  Breast Cancer Res Treat       Date:  2021-01-04       Impact factor: 4.872

9.  Methodology of the DCCSS later fatigue study: a model to investigate chronic fatigue in long-term survivors of childhood cancer.

Authors:  Adriaan Penson; Sylvia van Deuren; Ewald Bronkhorst; Ellen Keizer; Tom Heskes; Marieke J H Coenen; Judith G M Rosmalen; Wim J E Tissing; Helena J H van der Pal; Andrica C H de Vries; Marry M van den Heuvel-Eibrink; Sebastian Neggers; Birgitta A B Versluys; Marloes Louwerens; Margriet van der Heiden-van der Loo; Saskia M F Pluijm; Martha Grootenhuis; Nicole Blijlevens; Leontien C M Kremer; Eline van Dulmen-den Broeder; Hans Knoop; Jacqueline Loonen
Journal:  BMC Med Res Methodol       Date:  2021-05-16       Impact factor: 4.615

10.  Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events.

Authors:  Julie R Brahmer; Hamzah Abu-Sbeih; Paolo Antonio Ascierto; Jill Brufsky; Laura C Cappelli; Frank B Cortazar; David E Gerber; Lamya Hamad; Eric Hansen; Douglas B Johnson; Mario E Lacouture; Gregory A Masters; Jarushka Naidoo; Michele Nanni; Miguel-Angel Perales; Igor Puzanov; Bianca D Santomasso; Satish P Shanbhag; Rajeev Sharma; Dimitra Skondra; Jeffrey A Sosman; Michelle Turner; Marc S Ernstoff
Journal:  J Immunother Cancer       Date:  2021-06       Impact factor: 13.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.